RecruitingNCT06395974

Fetal Renal Artery Doppler in Patients With Preeclampsia

Fetal Renal Artery Doppler in Patients With Preeclampsia and Its Role in Prediction of Adverse Neonatal Outcomes


Sponsor

Assiut University

Enrollment

88 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.


Eligibility

Sex: FEMALE

Inclusion Criteria6

  • a) Preeclampsia:
  • Women with preeclampsia \>28 weeks of pregnancy.
  • Singleton pregnancy.
  • Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data.
  • b) Control:
  • Women with healthy pregnancy matched by closest gestational age.

Exclusion Criteria5

  • ● Multiple pregnancy.
  • Known Congenital fetal malformations.
  • Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders.
  • Women unable to provide informed consent.
  • Women who refuse to participate

Interventions

OTHERfetal ultrasound

2D, 3D , Doppler ultrasound


Locations(1)

Assiut university hospital

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06395974


Related Trials